Moreover, clonogenic assays were employed to assess the impact of SAA1 on the clonogenic capacity of ovarian cancer cells, demonstrating that SAA1 knockdown led to a substantial decrease in clonogenicity, whereas SAA1 overexpression significantly enhanced this capacity (Fig. 2O-R). Here, SAA1 is linked to ovarian carcinoma.